| Patient-derived organoids model treatment response of metastatic gastrointestinal cancers G Vlachogiannis, S Hedayat, A Vatsiou, Y Jamin, J Fernández-Mateos, ... Science 359 (6378), 920-926, 2018 | 1615 | 2018 |
| PI3KCA/PTEN deregulation contributes to impaired responses to cetuximab in metastatic colorectal cancer patients F Perrone, A Lampis, M Orsenigo, M Di Bartolomeo, A Gevorgyan, M Losa, ... Annals of oncology 20 (1), 84-90, 2009 | 488 | 2009 |
| MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancer N Valeri, C Braconi, P Gasparini, C Murgia, A Lampis, V Paulus-Hock, ... Cancer cell 25 (4), 469-483, 2014 | 325 | 2014 |
| Effect of pathologic tumor response and nodal status on survival in the medical research council adjuvant gastric infusional chemotherapy trial EC Smyth, M Fassan, D Cunningham, WH Allum, AFC Okines, A Lampis, ... Journal of Clinical Oncology 34 (23), 2721-2727, 2016 | 279 | 2016 |
| MicroRNAs (miRNAs) and long non-coding RNAs (lncRNAs) as new tools for cancer therapy: first steps from bench to bedside M Ratti, A Lampis, M Ghidini, M Salati, MB Mirchev, N Valeri, JC Hahne Targeted oncology 15, 261-278, 2020 | 260 | 2020 |
| Microsatellite instability in gastric cancer: molecular bases, clinical perspectives, and new treatment approaches M Ratti, A Lampis, JC Hahne, R Passalacqua, N Valeri Cellular and Molecular Life Sciences 75, 4151-4162, 2018 | 237 | 2018 |
| Longitudinal liquid biopsy and mathematical modeling of clonal evolution forecast time to treatment failure in the PROSPECT-C phase II colorectal cancer clinical trial KH Khan, D Cunningham, B Werner, G Vlachogiannis, I Spiteri, T Heide, ... Cancer discovery 8 (10), 1270-1285, 2018 | 219 | 2018 |
| miRNA profiling in colorectal cancer highlights miR-1 involvement in MET-dependent proliferation JF Reid, V Sokolova, E Zoni, A Lampis, S Pizzamiglio, C Bertan, S Zanutto, ... Molecular Cancer Research 10 (4), 504-515, 2012 | 156 | 2012 |
| MIR21 drives resistance to heat shock protein 90 inhibition in cholangiocarcinoma A Lampis, P Carotenuto, G Vlachogiannis, L Cascione, S Hedayat, ... Gastroenterology 154 (4), 1066-1079. e5, 2018 | 116 | 2018 |
| Personalized molecular targeted therapy in advanced, recurrent hepatocellular carcinoma after liver transplantation: a proof of principle S Bhoori, S Toffanin, C Sposito, A Germini, A Pellegrinelli, A Lampis, ... Journal of hepatology 52 (5), 771-775, 2010 | 104 | 2010 |
| Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers P Carotenuto, M Fassan, R Pandolfo, A Lampis, C Vicentini, L Cascione, ... Gut 66 (7), 1268-1277, 2017 | 89 | 2017 |
| Functional imaging and circulating biomarkers of response to regorafenib in treatment-refractory metastatic colorectal cancer patients in a prospective phase II study K Khan, M Rata, D Cunningham, DM Koh, N Tunariu, JC Hahne, ... Gut 67 (8), 1484-1492, 2018 | 74 | 2018 |
| Integrative approach for prioritizing cancer genes in sporadic colon cancer JF Reid, M Gariboldi, V Sokolova, P Capobianco, A Lampis, F Perrone, ... Genes, Chromosomes and Cancer 48 (11), 953-962, 2009 | 68 | 2009 |
| KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer F Sclafani, I Chau, D Cunningham, JC Hahne, G Vlachogiannis, Z Eltahir, ... Scientific reports 8 (1), 1445, 2018 | 64 | 2018 |
| Circulating free DNA in a screening program for early colorectal cancer detection F Perrone, A Lampis, C Bertan, P Verderio, CM Ciniselli, S Pizzamiglio, ... Tumori Journal 100 (2), 115-121, 2014 | 59 | 2014 |
| Characterisation of the immune-related transcriptome in resected biliary tract cancers M Ghidini, L Cascione, P Carotenuto, A Lampis, F Trevisani, MC Previdi, ... European Journal of Cancer 86, 158-165, 2017 | 57 | 2017 |
| Vault RNAs: hidden gems in RNA and protein regulation JC Hahne, A Lampis, N Valeri Cellular and Molecular Life Sciences 78, 1487-1499, 2021 | 45 | 2021 |
| Molecular characterization of synovial sarcoma in children and adolescents: evidence of akt activation F Bozzi, A Ferrari, T Negri, E Conca, M Losa, P Casieri, M Orsenigo, ... Translational Oncology 1 (2), 95-101, 2008 | 42 | 2008 |
| miR-31-3p expression and benefit from anti-EGFR inhibitors in metastatic colorectal cancer patients enrolled in the prospective phase II PROSPECT-C trial G Anandappa, A Lampis, D Cunningham, KH Khan, K Kouvelakis, ... Clinical Cancer Research 25 (13), 3830-3838, 2019 | 41 | 2019 |
| Lack of KRAS, NRAS, BRAF and TP53 mutations improves outcome of elderly metastatic colorectal cancer patients treated with cetuximab, oxaliplatin and UFT M Di Bartolomeo, F Pietrantonio, F Perrone, KF Dotti, A Lampis, C Bertan, ... Targeted oncology 9, 155-162, 2014 | 40 | 2014 |
